Position Statements
Human Chorionic Gonadotropin (HCG) - An Ineffective Approach to Treating Obesity, Jan. 29, 2013
Obesity Community Statement on the Future of Obesity Drugs
The Need for Increased Obesity Research Funding
Youth Weight Bias and Bullying in Schools
Statement of The Obesity Society Regarding FDA Review and Approval of Promising New Obesity Drugs
Weight Bias and Discrimination
Youth Weight Bias and Discrimination in Healthcare Settings
Employer Incentives and Penalties Regarding BMI and Weight Loss
The Obesity Society Opposes Georgia’s Children’s Health Alliance Campaign to Stop Childhood Obesity
The Obesity Society Calls Billboard Campaign Offensive and Off-Target
The Obesity Society Position on Recent Criticism of Surgeon General Nominee Regina Benjamin
Solutions- Eradicating America's Obesity Epidemic
Obesity As a Disease: The Obesity Society Resolution
Obesity As a Disease: White Paper
Position Statement on Restaurant Labeling
Draft Guidance for Industry on Developing Products for Weight Management
NAASO, The Obesity Society’s Position on Orlistat as an Over-the-Counter Drug
The Obesity Society's Comments on Coverage Review of Bariatric Surgery
Weight Bias Task Force Issues Policy Statement
The Obesity Society's Comments on Medicare Policy
The Obesity Society's Testimony Before Congress
Statement Regarding the Use of Pharmacotherapy in Response to a Public Citizen Petition
National Nutrition Summit Position Paper
The Obesity Society's Council Urges All Members to Actively Support H.R. 88
Report On The Supply And Demand Of 18O Enriched Water
The Obesity Society's Comments on Healthy People 2010
Question about a TOS position? Contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it .
need to create individual pages for each
